
Sign up to save your podcasts
Or


Welcome to another episode of Integrative Lyme Solutions! Today are honored to have Dr. Armin Schwarzbach with us, the founder of Armin Labs in Augsburg, Germany. Today we talk about the challenges of diagnosing and treating Lyme disease, given its complexity and potential for co-infections. We discuss the inadequacy of the commonly used ELISA test and underline the importance of newer tests like the ELISBOT. Dr. Armin shares his '3i model' in treating Lyme disease which involves addressing infection, inflammation, and the immune system. We also discuss the critical role of antibiotics, the danger of biofilms, and the need for a more holistic approach to treatment, which might also include changes in diet and lifestyle.
Dr. Armin's website: www.arminlabs.com
By Dr.Karlfeldt | SB Studios5
2828 ratings
Welcome to another episode of Integrative Lyme Solutions! Today are honored to have Dr. Armin Schwarzbach with us, the founder of Armin Labs in Augsburg, Germany. Today we talk about the challenges of diagnosing and treating Lyme disease, given its complexity and potential for co-infections. We discuss the inadequacy of the commonly used ELISA test and underline the importance of newer tests like the ELISBOT. Dr. Armin shares his '3i model' in treating Lyme disease which involves addressing infection, inflammation, and the immune system. We also discuss the critical role of antibiotics, the danger of biofilms, and the need for a more holistic approach to treatment, which might also include changes in diet and lifestyle.
Dr. Armin's website: www.arminlabs.com

770 Listeners

376 Listeners

7,217 Listeners

5,004 Listeners

721 Listeners

708 Listeners

9,217 Listeners

74 Listeners

55 Listeners

810 Listeners

36 Listeners

293 Listeners

17 Listeners

5 Listeners

17 Listeners

0 Listeners

560 Listeners

0 Listeners

3 Listeners

5 Listeners

6 Listeners

19 Listeners

7 Listeners

23 Listeners

5 Listeners

0 Listeners

4 Listeners

0 Listeners

0 Listeners

0 Listeners

5 Listeners

0 Listeners

0 Listeners

0 Listeners